1 / 19

FACULTY OF PHARMACEUTICAL MEDICINE of the Royal Colleges of Physicians of the United Kingdom

National Deanery in Pharmaceutical Medicine Specialty Training Update 3 rd National Trainees Meeting Alan Boyd Chair, SAC – Pharmaceutical Medicine May 2011. NATIONAL DEANERY OF PHARMACEUTICAL MEDICINE. FACULTY OF PHARMACEUTICAL MEDICINE

hawa
Download Presentation

FACULTY OF PHARMACEUTICAL MEDICINE of the Royal Colleges of Physicians of the United Kingdom

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Deanery in Pharmaceutical Medicine Specialty Training Update 3rd National Trainees Meeting Alan Boyd Chair, SAC – Pharmaceutical Medicine May 2011 NATIONAL DEANERY OF PHARMACEUTICAL MEDICINE FACULTY OF PHARMACEUTICAL MEDICINE of the Royal Colleges of Physicians of the United Kingdom

  2. Introduction: • Pharmaceutical Medicine Specialty Training: • Higher Medical Training commenced in UK on 1 April 2003 • following the recognition & listing of the medical Specialty • of Pharmaceutical Medicine on 22 April 2002 • PMST (PMST1) superseded HMT on 1 August 2007 • PMST2 (curriculum 2010) superseded PMST1 on 1st • August 2010 - formal introduction of workplace based • assessments (WPBAs) and the introduction of the • e-Portfolio to replace the paper-based Training Record.

  3. Current Status - Trainees • 148 Pharmaceutical Physicians now hold a CCT in • Pharmaceutical Medicine • 213 Trainees now hold an NTN • 196 via the CCT route • 17 via the Combined CESR route • HMT - 77 • PMST1 - 103 • PMST2 - 33 • Local Educational Providers: 66 Sites • 31 LEPs have more than 1 Trainee • Top-Ten have between 5-25 • 35 have 1 Trainee • 7 Trainees working outside the UK in approved LEPs

  4. Current Status - Trainees • 43 Trainees have resigned from the programme • since 2005 – moved out of UK, left Pharmaceutical • Medicine or personal reasons • Current rate of enrolment is about 25 new Trainees • per annum • In total, 392 doctors have enrolled in HMT/PMST since 2003

  5. Current Status – Specialty League Table • 34 Specialties within JRCTB • Largest is General Internal Medicine – 3258 Trainees • Smallest is Metabolic Medicine – 3 Trainees • Pharmaceutical Medicine is the 12th largest • Similar size to Acute Medicine, Neurology & • Rheumatology • Larger than Medical Oncology, Dermatology & • Infectious Diseases

  6. Governance & Supervision • The National Deanery of Pharmaceutical Medicine Deanery • (comprising the Lead Postgraduate Dean and Faculty of • Pharmaceutical Medicine), in conjunction with the Joint • Royal Colleges of Physicians' Training Board (JRCPTB), is • responsible for PMST and reports to the GMC • The first and only National Deanery – others currently • being modelled on our experiencies • All Specialties are governed by the same GMC Regulations

  7. Senior Specialty Advisers (SSAs) • 31 active SSAs - role is governance and quality management • over the PMST programme in training organisations. • Each SSA is allocated sites within their geographical reach and • have between 1-7 sites each, covering 1-20 trainees for each • SSA • SSAs also serve on ARCP/RITA Panels to review & evaluate • trainees’ progress & achievement on an annual basis. • Majority of SSAs are Fellows of Faculty • 4 SSAs also hold a CCST/CCT in Pharmaceutical Medicine.

  8. Educational Supervisors (ESs) • There are currently 150 Trained & Approved ESs • Over 100 ESs are currently active • Supervise 1-2 Trainees each – though a few have 3-5 • Supervision estimated to take 1 hour per week • ESs can become ‘Accredited Educational Supervisors’ • 46 ESs & SSAs (28%) now hold a CCT in Pharmaceutical Medicine

  9. Conduct of HMT/PMST • Approximately 70% of HMT/PMST takes place • on-the-job in the work place • Approximately 30% of HMT/PMST takes place • through taught courses • Approved External Modular Courses: • King’s College London – RGN, CLP, CLD • Parexel (Richard Kay) – SDM • DSRU, Southampton – DSS • New Courses at Kings – HMP & Bath Univ - DSS

  10. Diploma in Pharmaceutical Medicine Exam :

  11. Diploma in Pharmaceutical Medicine Exam : • Current Situation • 213 active Trainees – 48 have passed the DPM • 165 Trainees need to sit or re-sit the DPM prior to • completing CCT • Of the Trainees who commenced in or before 2009 • - 122 could or should sit the 2011 exam • - 38 Re-sits & 84 First time • - All 122 need to pass exam either in 2011,2012 or 2013 • Failure to sit or pass the DPM is main reason for RITA E or • Outcome 3 • 46 RITA D or Es/Outcome 2 or 3 issued to date • - 41 due to failure to pass DPM within CCT Timeline • (Failed or not taken exam)

  12. Organisation of the National Deanery & QM Processes: SAC-PM & National Deanery Senior Specialty Advisers (SSA) GMC Local Educational Providers Companies & Trainers (ES &AES) Trainees

  13. Organisation of the National Deanery & QM Processes: • QA of External Courses • Trainee Progression – RITA/ARCPs • QM Process of the PMST Programme by the • National Deanery in Pharmaceutical Medicine • Annual Report to GMC • Includes Issues and Good Practice • –SSA Input • Trainee & Trainer Surveys • – Trainee & ES Input

  14. Annual Deanery Report to GMC - 2010 • GMC recently confirmed continuation of approval for the Pharmaceutical Medicine National Deanery • Items of Good Practice: • Face-to-Face ARCPs & RITAs • Review & Evaluation of External Courses against Curriculum • Trainees working in Teams – • e.g. No single trainee signs off a Clinical Study Protocol • Bespoke ‘effective ES Training Programme’ • Extensive online E-Learning enables Curriculum delivery – • e.g. Roche & GSK • Areas for Attention: • Information on Formative Assessments for Trainees on • Pre-2010 Curriculum • Information on Schedule for Visits to LEPs

  15. Peer Support Group for PMST • Acknowledgement and thanks should be given to the large support • group that HMT/PMST has acquired over the years, including trainees, • numbering almost 600 people comprising: • SSAs, ESs, AESs, Lead Postgraduate Dean, • E&T Committees (SAC-PM; FPM Education Committee; • Trainees Subcommittee, Working Groups (especially CAWG)), • JRCPTB Administrators, • Faculty Education and Standards Administrators, • Education Department RCP, • Faculty Board of Examiners, • Modular Course Providers and course Faculties, • Modular Course QM Convenors Group and QM Panellists, • Postgraduate courses in Pharmaceutical Medicine & their Faculties, • Company Management, • Lay Representatives, • and of course you the Trainees.

  16. CCT in Pharmaceutical Medicine • Summary of 2003 to 2011 • Pharmaceutical Medicine Specialty training • is now in its 9th Year • Nearly 400 Doctors have enrolled into the • programme to date • Currently there are 213 active Trainees • Now 12th Largest Medical Specialty • 148 CCTs have been awarded to individuals who are now acknowledged Specialists in Pharmaceutical Medicine

  17. 3rd National Trainees Meeting • A few Questions from me: • The CCT in Pharmaceutical Medicine – • Why do you want a CCT in Pharmaceutical • Medicine? • What do you get out of it? • Does your Company/Organisation recognise its • importance? • What does your Company/Organisation get out of it?

  18. QUESTIONS & Thanks !

  19. National Deanery of Pharmaceutical Medicine & Faculty of Pharmaceutical Medicine Of the Royal Colleges of Physicians of the United Kingdom 1 St Andrew’s Place Regent’s Park London NW1 4LB

More Related